Dova Pharmaceuticals, Inc. (DOVA) has 40 open-market insider trades by 13 insiders since 2017. The most active filer is Paul B. Manning, Director & 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Perceptive Advisors LLC | 10% Owner | — | 5 | $21.2M | 2019-07-05 |
| Paul B. Manning | Dir10% Owner | — | 10 | $16.3M | 2019-11-12 |
| Perceptive LIFE Sciences Master FUND Ltd. via Joseph Edelman | 10% Owner | — | 4 | $7.3M | 2019-07-03 |
| Joseph Edelman | 10% Owner | — | 1 | $2.8M | 2019-11-12 |
| Steven M. Goldman | Dir | — | 4 | $1.5M | 2019-11-12 |
| Alex Sapir | CEOPres | — | 2 | $1.3M | 2018-08-14 |
| Roger Jeffs | Dir | — | 2 | $900K | 2019-11-12 |
| David Zaccardelli | CEOPres | — | 3 | $374K | 2019-11-12 |
| Kevin Laliberte | VP | — | 3 | $254K | 2019-11-12 |
| Jason Hoitt | CCO | — | 3 | $201K | 2019-11-12 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| David Zaccardelli | CEO & President | Sell | $294K | 2019-10-01 |
| Jason Hoitt | CCO | Sell | $67K | 2019-09-30 |
| Mark W. Hahn | CFO | Sell | $22K | 2019-09-30 |
| Kevin Laliberte | VP | Sell | $103K | 2019-09-30 |
| Lee F. Allen M.D. Ph.D. | Chief Medical Officer | Sell | $27K | 2019-09-30 |
| Kevin Laliberte | VP | Sell | $62K | 2019-09-25 |
Companies that share insiders with DOVA, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Paul B. Manning | Director & 10% Owner | Buy | $891K | 2019-08-09 |
| Kevin Laliberte | Sr. VP & Product Development | Sell | $22K | 2019-07-31 |
| Jason Hoitt | CCO | Sell | $116K | 2019-07-15 |
| Joseph Edelman | 10% Owner | Buy | $2.8M | 2019-07-09 |
| Perceptive Advisors LLC | 10% Owner | Buy | $823K | 2019-07-05 |
| David Zaccardelli | CEO & President | Sell | $333K | 2019-07-02 |
| Mark W. Hahn | CFO | Sell | $22K | 2019-07-01 |
| Perceptive LIFE Sciences Master FUND Ltd. | 10% Owner | Buy | $556K | 2019-07-01 |
| Kevin Laliberte | Sr. VP & Product Development | Sell | $17K | 2019-07-01 |